Advanced search
Publication Cover
Acta Cardiologica Volume 65, 2010 - Issue 1
Submit an article Journal homepage
4
Views
0
CrossRef citations to date
0
Altmetric
Articles

Usefulness of 6-minute walk test, plasma neurohumoral and cytokine activation in the assessment of symptomatic patients with left ventricle dysfunction caused by chronic severe mitral valve regurgitation

Przemys¥aw LeszekNational Institute of Cardiology, Warszawa, PolandCorrespondence[email protected]
, MD, PhD,
Anna KlisiewiczNational Institute of Cardiology, Warszawa, Poland
, MD, PhD,
Jadwiga JanasNational Institute of Cardiology, Warszawa, Poland
, MD, PhD,
Andrzej BiedermanNational Institute of Cardiology, Warszawa, Poland
, MD, PhD,
Walerian PiotrowskiNational Institute of Cardiology, Warszawa, Poland
, MD, PhD,
Tomasz RywikNational Institute of Cardiology, Warszawa, Poland
, MD, PhD &
Jerzy KorewickiNational Institute of Cardiology, Warszawa, Poland
, MD, PhD show all
Pages 43-51 | Received 22 Nov 2007, Accepted 10 Dec 2009, Published online: 23 May 2017

References

  • Carabello BA. The ten most commonly asked questions about mitral regurgitation. Cardiol Rev 2002; 10: 321–2.
  • Detaint D, Messika-Zeitoun D, Avierinos JF, Scott C, Chen H, Burnett JC, Jr., Enriquez-Sarano M. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation 2005; 111: 2391–7.
  • Yusoff R, Clayton N, Keevil B, Morris J, Ray S. Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation. Am J Cardiol 2006; 97: 1498–1501.
  • Tavel ME, Carabello BA. Chronic mitral regurgitation: when and how to operate. Chest 1998; 113: 1399–1401.
  • Kapadia SR, Yakoob K, Nader S, Thomas JD, Mann DL, Griffin BP. Elevated circulating levels of serum tumor necro-sis factor-alpha in patients with hemodynamically signifi-cant pressure and volume overload. J Am Coll Cardiol 2000; 36: 208–12.
  • Carabello BA. Indications for mitral valve surgery. J Car-diovasc Surg (Torino) 2004; 45: 407–18.
  • Le Tourneau T, de Groote P, Millaire A, Foucher C, Savoye C, Pigny P. Prat A, Warembourg H, Lablanche JM. Effect of mitral valve surgery on exercise capacity, ventricular ejection fraction and neurohormonal activation in patients with severe mitral regurgitation. J Am Coll Cardiol 2000; 36: 2263–9.
  • Jourdain P, Funck F, Bellorini M, Guillard N, Loiret J, Thebault B, Desnos M, Duboc D. Bedside B-type natriuretic peptide and functional capacity in chronic heart failure. Eur J Heart Fail 2003; 5: 155–60.
  • Hirata Y, Matsumoto A, Aoyagi T, Yamaoki K, Komuro I, Suzuki T, Ashida T, Sugiyama T, Hada Y, Kuwajima I, Nishinaga M, Akioka H, Nakajima O, Nagai R, Yazaki Y. Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload. Cardiovasc Res 2001; 51: 585–91.
  • Golbasy Z, Ucar O, Yuksel AG, Gulel O, Aydogdu S, Ulu-soy V. Plasma brain natriuretic peptide levels in patients with rheumatic heart disease. Eur J Heart Fail 2004; 6: 757–60.
  • Watanabe M, Murakami M, Furukawa H, Nakahara H. Is measurement of plasma brain natriuretic peptide levels a useful test to detect for surgical timing of valve disease? Int J Cardiol 2004; 96: 21–4.
  • Mayer SA, De Lemos JA, Murphy SA, Brooks S, Roberts BJ, Grayburn PA. Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation. Am J Cardiol 2004; 93: 1002–6.
  • Brookes CI, Kemp MW, Hooper J, Oldershaw PJ, Moat NE. Plasma brain natriuretic peptide concentrations in patients with chronic mitral regurgitation. J Heart Valve Dis 1997; 6: 608–12.
  • Sutton TM, Stewart RA, Gerber IL, West TM, Richards AM, Yandle TG, Kerr AJ. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003; 41: 2280–7.
  • Tanaka T, Hasegawa K, Fujita M, Tamaki SI, Yamazato A, Kihara Y, Nohara R, Sasayama S. Marked elevation of brain natriuretic peptide levels in pericardial fluid is closely asso-ciated with left ventricular dysfunction. J Am Coll Cardiol 1998; 31: 399–403.
  • Mehta RH, Supiano MA, Oral H, Grossman PM, Petrusha JA, Montgomery DG, Briesmiester KA, Smith MJ, Starling MR. Relation of systemic sympathetic nervous system activation to echocardiographic left ventricular size and performance and its implications in patients with mitral regurgitation. Am J Cardiol 2000; 86: 1193–7.
  • Mehta RH, Supiano MA, Oral H, Grossman PM, Mont-gomery DS, Smith MJ, Starling MR. Compared with con-trol subjects, the systemic sympathetic nervous system is activated in patients with mitral regurgitation. Am Heart J 2003; 145: 1078–85.
  • Dzimiri N, Moorji A, Kumar M, Kumar N, Halees Z. Com-parison of the effect of left ventricular volume and pressure overload on beta-adrenoceptor density in left heart valvular disease. Int J Cardiol 1996; 53: 109–16.
  • Mehta RH, Supiano MA, Grossman PM, Oral H, Mont-gomery DG, Briesmiester KA, Smith MJ, Starling MR. Changes in systemic sympathetic nervous system activity after mitral valve surgery and their relationship to changes in left ventricular size and systolic performance in patients with mitral regurgitation. Am Heart J2004; 147: 729–35.
  • Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996; 27: 1201–6.
  • Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-alpha andtumor necrosis factor receptors in the failing human heart. Circulation 1996; 93: 704–11.
  • Boffa GM, Zaninotto M, Nalli C, Forth M, Tiso E, Raz-zolini R, Plebani M. Plasma levels of tumor necrosis fac-tor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure. Rai Heart J 2004; 5: 48–52.
  • Oral H, Sivasubramanian N, Dyke DB, Mehta RH, Gross-man PM, Briesmiester K, Fay WP, Pagani FD, Bolling SF, Mann DL, Starling MR. Myocardial proinflammatory cytokine expression and left ventricular remodeling in patients with chronic mitral regurgitation. Circulation 2003; 107: 831–7.
  • Leszek P, Janas J, Klisiewicz A, Biederman A, Rywik T, Kopacz M, Browarek A, Korewicki J. Mitral valve regurgi-tation and plasma neurohumoral and cytokine activation. Acta Cardiol 2004; 59: 208–10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.